Clinical Observation on Integrative Medicine in Treatment of Ankylosing Spondylitis
Renpeng Wang
Abstract
Renpeng Wang
Abstract
Objective: To observe the clinical efficacy of the integrative medicine treatment of ankylosing spondylitis.Methods: 80 cases diagnosized as ankylosing spondylitis were randomly divided into a treatment group and the control group,n=40 cases.The treatment group received Western medicine sulfasalazine enteric-coated tablets and Compound Chlorzoxazone tablet.Treatment group on the basis of the control group treatment,added self-made Bushen Xuanbi Decociton orally,making modification according to the syndrome differentiation.The clinical efficacy was observed after the end of treatment.Results: The treatment group total effective rate was 87.5% and in the control group the total effective rate was 62.5%,and there was a significant difference(P0.05).Before and after treatment,signs and symptoms had significant difference(P0.05),as shown in Table 2.C-reactive protein and erythrocyte sedimentation rate in the treatment group patients after treatment were significantly reduced than that before treatment(P0.05),immunoglobulin was significantly reduced after the treatment(P0.05).Conclusion: Integrative treatment of ankylosing spondylitis can improve the clinical efficacy,and it is worthy of promotion.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To observe the clinical efficacy of the integrative medicine treatment of ankylosing spondylitis.Methods: 80 cases diagnosized as ankylosing spondylitis were randomly divided into a treatment group and the control group,n=40 cases.The treatment group received Western medicine sulfasalazine enteric-coated tablets and Compound Chlorzoxazone tablet.Treatment group on the basis of the control group treatment,added self-made Bushen Xuanbi Decociton orally,making modification according to the syndrome differentiation.The clinical efficacy was observed after the end of treatment.Results: The treatment group total effective rate was 87.5% and in the control group the total effective rate was 62.5%,and there was a significant difference(P0.05).Before and after treatment,signs and symptoms had significant difference(P0.05),as shown in Table 2.C-reactive protein and erythrocyte sedimentation rate in the treatment group patients after treatment were significantly reduced than that before treatment(P0.05),immunoglobulin was significantly reduced after the treatment(P0.05).Conclusion: Integrative treatment of ankylosing spondylitis can improve the clinical efficacy,and it is worthy of promotion.
Key concepts: Ankylosing spondylitis, Medicine, Erythrocyte sedimentation rate, Sulfasalazine, Treatment and control groups, Clinical efficacy, Internal medicine, Western medicine